The American Journal of Managed Care > September 2014

The American Journal of Managed Care - September 2014

September 17, 2014 – Robin R. Whitebird, PhD, MSW; Leif I. Solberg, MD; Nancy A. Jaeckels, BS; Pamela B. Pietruszewski, MA; Senka Hadzic, MPH; Jürgen Unützer, MD, MPH, MA; Kris A. Ohnsorg, MPH, RN; Rebecca C. Rossom, MD, MSCR; Arne Beck, PhD; Kenneth E. Joslyn, MD, MPH; and Lisa V. Rubenstein, MD, MSPH
Factors most important for successful implementation of collaborative care for depression differ for patient activation versus achieving remission; both are critical to program success.
September 17, 2014 – Vanja Sikirica, PharmD, MPH; Steven R. Pliszka, MD; Keith A. Betts, PhD; Paul Hodgkins, PhD, MSc; Thomas M. Samuelson, BA; Jipan Xie, MD, PhD; M. Haim Erder, PhD; Ryan S. Dammerman, MD, PhD; Brigitte Robertson, MD; and Eric Q. Wu, PhD
A retrospective study of the treatment patterns and economic outcomes associated with off-label atypical antipsychotic use in the treatment of adolescents with attention-deficit/hyperactivity disorder.
September 17, 2014 – Gerry Oster, PhD, and A. Mark Fendrick, MD
The authors comment on the growth of drug plans with tiers for "non-preferred" generics, and argue that most are inconsistent with established principles of formulary design.
September 17, 2014 – James F. Burke, MD, MS; Sandeep Vijan, MD; Lynette A. Chekan, MBA; Ted M. Makowiec, MBA; Laurita Thomas, MEd; and Lewis B. Morgenstern, MD
Targeting cardiovascular risk reduction interventions to high-risk patients has the potential to reduce cardiovascular racial disparities, improve health, and reduce costs.
September 17, 2014 – Seth Joseph, MBA; Max Sow, MBA; Michael F. Furukawa, PhD; Steven Posnack, MS, MHS; and Mary Ann Chaffee, MS, MA
This is the first empirical evidence to demonstrate increased competition and innovation in the EHR industry as a result of the HITECH program.
September 17, 2014 – Pamela N. Roberto, MPP, and Bruce Stuart, PhD
Out-of-plan medication use accounted for a small share of diabetes, hypertension, and hyperlipidemia prescriptions filled by Medicare Part D beneficiaries.
September 17, 2014 – John W. Peabody, MD, PhD, DTM&H, FACP; Riti Shimkhada, PhD; Kuo B. Tong, MS; and Matthew B. Zubiller, MBA
The authors describe 5 basic requirements for planning, implementing, and proving clinical utility for diagnostic tests, drawing on recent reimbursement decisions.
September 23, 2014 – Shivan J. Mehta, MD, MBA; and Scott Manaker, MD, PhD
Due to existing payment structures and practice patterns for colonoscopy, reducing endoscopist reimbursement may diminish access to and quality of colorectal cancer screening.
October 01, 2014 – James C. Robinson, PhD, and Timothy T. Brown, PhD
The authors quantify the potential reduction in hospital costs from adopting best local practices in supply chain management and discharge planning within a major metropolitan market.
October 01, 2014 – Harn-Shen Chen, MD, PhD; Tzu-En Wu, MD; and Chin-Sung Kuo, MD
The authors evaluate long-term glycemic control in a 5-year follow-up period after patients with newly diagnosed type 2 diabetes mellitus with severe hyperglycemia were treated with 6 months of basal insulin therapy in a randomized controlled trial.
October 01, 2014 – Zhen-qiang Ma, MD, MPH, MS, and Monica A. Fisher, PhD, DDS, MS, MPH
Diabetes-related hospital charges are driven by complications, hospital misadventures, procedures, and other patient and discharge characteristics. Readmission charges are not different from initial admission charges.
October 08, 2014 – Lindsey Jeanne Leininger, PhD; Donna Friedsam, MPH; Kristen Voskuil, MA; and Thomas DeLeire, PhD
Self-reported health measures embedded in a Medicaid application can comprise a predictive model identifying new and returning enrollees at risk of high healthcare utilization.
October 08, 2014 – Woan Shin Tan, BSocSc, MSocSc; Yew Yoong Ding, MBBS, FRCP, MPH; Wu Christine Xia, BS(IT); and Bee Hoon Heng, MBBS, MSc
Patients utilizing Medisave for a diabetes management program in Singapore were more compliant with care processes, but reductions in hospitalization and costs were not sustained.
October 23, 2014 – Sarah J. Billups, PharmD; Lindsy R. Moore, PharmD; Kari L. Olson, BSc (Pharm), PharmD; and David J. Magid, MD, MPH
A technology-based, pharmacist-run home blood pressure monitoring program improves health outcomes by investing $20.50 per mm Hg systolic blood pressure lowered and $3300 per life-year gained.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.